Roche Seeks NJ High Court Review Of Accutane Expert Ruling

By Bill Wichert (August 29, 2017, 4:00 PM EDT) -- Hoffmann-La Roche Ltd. on Monday urged the New Jersey Supreme Court to review a state appellate decision reviving more than 2,000 cases alleging the company's acne medication Accutane caused patients to develop Crohn's disease, saying the court needed to clarify the appropriate degree of judicial scrutiny in evaluating expert testimony....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read the full article

Already a subscriber? Click here to login